Millipore Expands BioPharma CRO Services in Europe

25-May-2010 - United Kingdom

Millipore Corporation has moved its European BioPharma services unit to new, expanded facilities to accommodate strong growth in the biotechnology sector. The new facilities are located in Milton Park, near Didcot in Oxfordshire, England.

Millipore’s BioPharma Services unit is the first global contract research organization (CRO) dedicated exclusively to large molecule bioanalytical work. The unit arose from Millipore’s acquisition in August, 2009 of BioAnaLab, which specializes in the analysis of biopharmaceuticals and has been supporting drug development for the pharmaceutical industry for the past several years.

Geoff Hale, Managing Director of BioAnaLab said: “The new laboratory provides us with space to continue our growth as we expand the range of services we provide.” Craig Morley, Global Managing Director of Millipore’s BioPharma Services added: “"The new facility complements the outstanding facilities at our St. Charles site and is a significant milestone in our development as "The World's Large Molecule Lab."

Other news from the department manufacturing

Most read news

More news from our other portals

Fighting cancer: latest developments and advances